Phage Hunters Training and Research Program

𝗣𝗛𝗧𝗥𝗣 — 𝗣𝗵𝗮𝗴𝗲 𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗙𝘂𝗻𝗱 Antimicrobial resistance (AMR) is a growing global crisis, projected to cause 10 million deaths annually by 2050. The urgent need for innovative solutions to combat antibiotic-resistant bacteria has never been clearer. In response to this critical challenge, the Phage Hunters Training and Research Program (PHTRP) is dedicated to inspiring and equipping the next generation of scientists in Africa and other developing countries to advance phage research.   𝗠𝗶𝘀𝘀𝗶𝗼𝗻: We aim to empower young scientists, particularly undergraduates, by providing mentorship and guidance to overcome barriers in pursuing research careers. This initiative not only addresses the critical shortage of researchers focusing on antimicrobial resistance (AMR) but also encourages the development of innovative therapeutics, such as bacteriophages, to combat this pressing issue.   𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻: We offer a comprehensive research and training initiative designed to nurture young scientists and foster scientific entrepreneurship. Through hands-on training, mentorship, and support, we are cultivating a new generation of phage researchers equipped to discover solutions for antibiotic-resistant bacteria and translate their innovations into impactful commercial ventures.   𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗨𝘀: The funds raised will be instrumental in covering the start-up registration costs for the Program. This includes critical legal fees, administrative expenses, and initial operational costs essential for our official launch. Your generous support will help us achieve our goal and make a profound impact in phage research. By investing in our program, you’re helping us inspire and equip young scientists to tackle antibiotic resistance and drive forward groundbreaking solutions in global health.   𝗗𝗼𝗻𝗮𝘁𝗶𝗼𝗻 𝗟𝗶𝗻𝗸: https://shorturl.at/SNrqn World Anti-Microbial Resistance Congress Tobi Nagel Africa CDC Howard Hughes Medical Institute (HHMI) World Health Organization ReAct - Action on Antibiotic Resistance Students Against Superbugs Africa AMR Now Global Leaders Group on AMR Global AMR R&D Hub The AMR Narrative AMR Initiative Rwanda Ethiopia AMR Initiative Targeting Phage Therapy Phage Kenya Consortium Phage Directory Centers for Disease Control and Prevention USAID - Center for Innovation and Impact (CII) Center for Innovative Phage Applications and Therapeutics (IPATH) George Eliava Institute of Bacteriophages, Microbiology and Virology Kenya Medical Research Institute (KEMRI) KEMRI - Wellcome Trust Phages IPR Phage Asia Phage Therapeutics PhageLab Kenya Institute of Primate Research United Nations Environment Programme Finance Initiative (UNEP FI) AMR Conference International Livestock Research Institute (ILRI) Martha Clokie Spyridon Megremis Steffanie Strathdee Wellcome Trust The Trinity Challenge World Anti-Microbial Resistance Congress #AntimicrobialResistance #PhageResearch #PhageTherapy #SupportUs

Listen to what Pablo Cifuentes Palma sees as a very bright future for phage therapy in the podcast #TheFutureOfPoultry, by 🐓 WATT Poultry. Our CTO had a great conversation with Mark K Clements; they talked about how phages are a powerful tool, their synergy with antibiotics, and why our proven results on farms make what lies ahead so promising for this technology. #ScienceWorks #Poultry #Phages

September is known as '𝘚𝘦𝘱𝘴𝘪𝘴 𝘈𝘸𝘢𝘳𝘦𝘯𝘦𝘴𝘴 𝘔𝘰𝘯𝘵𝘩.' Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its tissues and organs. September 13th, particularly, is designated as '𝗪𝗼𝗿𝗹𝗱 𝗦𝗲𝗽𝘀𝗶𝘀 𝗗𝗮𝘆 (𝗪𝗦𝗗),' to call for global action against sepsis. According to the World Health Organization (WHO) sepsis report, recent studies estimate that sepsis kills 11 million people annually—many of them children—and disables millions more. Almost half (20 million) of all estimated sepsis cases worldwide occurred in children under 5 years of age. Additionally, for every 1000 hospitalized patients, an estimated 15 patients will develop sepsis as a complication of receiving health care. Recent research has revealed that phages possess not only antibacterial properties but also significant immunomodulatory effects. These properties could help manage sepsis by modulating the immune response. Sepsis Alliance Sepsis Research Sepsis Stiftung Center for Sepsis Control & Care (CSCC) AWARE Sepsis DART™ - Detection And Response Tool World Anti-Microbial Resistance Congress ReAct - Action on Antibiotic Resistance Antibiotic Research UK Antimicrobial Resistance Fighter Coalition Targeting Phage Therapy Phage Therapeutics Aleksandra PETROVIC FABIJAN Jon Iredell Eliava Phage Therapy Center The Westmead Institute for Medical Research Jeremy Barr Drugs for Neglected Diseases initiative - DNDi Center for Innovative Phage Applications and Therapeutics (IPATH) Global Antibiotic R&D Partnership (GARDP) European Sepsis Alliance END SEPSIS, the Legacy of Rory Staunton The UK Sepsis Trust Stefan Schwartze Roland Göhde Huberta von Voss Simone Mancini #PhageResearch #PhageTherapy #AntimicrobialResistance #SepsisMonth #WorldSepsisDay #SepsisAwarenessMonth #OneHealth

𝐏𝐡𝐚𝐠𝐞 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐢𝐧𝐠 𝐏𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐢𝐜 𝐚𝐧𝐝 𝐒𝐩𝐨𝐢𝐥𝐚𝐠𝐞 𝐁𝐚𝐜𝐭𝐞𝐫𝐢𝐚 𝐢𝐧 𝐭𝐡𝐞 𝐅𝐨𝐨𝐝 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲⁣ Bacteriophages, are important in controlling pathogenic and spoilage bacteria in foods, particularly in foodborne diseases. Food is a primary channel for transmitting over 𝟐𝟎𝟎 𝐤𝐧𝐨𝐰𝐧 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬, most of which are bacterial in origin. Common foodborne pathogens like 𝘚𝘢𝘭𝘮𝘰𝘯𝘦𝘭𝘭𝘢, 𝘊𝘢𝘮𝘱𝘺𝘭𝘰𝘣𝘢𝘤𝘵𝘦𝘳, 𝘌𝘴𝘤𝘩𝘦𝘳𝘪𝘤𝘩𝘪𝘢 𝘤𝘰𝘭𝘪, and 𝘓𝘪𝘴𝘵𝘦𝘳𝘪𝘢 𝘮𝘰𝘯𝘰𝘤𝘺𝘵𝘰𝘨𝘦𝘯𝘦𝘴 cause severe gastrointestinal infections. These pathogens are naturally present in fresh and unprocessed foods and can significantly impact food safety and quality.⁣ ⁣ Phages are being used in the food industry to 𝐞𝐧𝐡𝐚𝐧𝐜𝐞 𝐟𝐨𝐨𝐝 𝐬𝐚𝐟𝐞𝐭𝐲, particularly by targeting harmful bacteria. They are applied both pre-and post-harvest to control dangerous pathogens. Several phage-based products have been approved for use on food products, such as ListShield and LISTEX to combat 𝘓. 𝘮𝘰𝘯𝘰𝘤𝘺𝘵𝘰𝘨𝘦𝘯𝘦𝘴, EcoShield for 𝘌. 𝘤𝘰𝘭𝘪 𝘖157⁣, and SALMONELEX for 𝘚𝘢𝘭𝘮𝘰𝘯𝘦𝘭𝘭𝘢.⁣ ⁣ Research into phage applications has shown promise in decontaminating livestock and reducing the risk of diseases entering the food supply. Studies have also focused on using phages to control 𝘓. 𝘮𝘰𝘯𝘰𝘤𝘺𝘵𝘰𝘨𝘦𝘯𝘦𝘴 in various foods, with notable success in reducing bacterial counts. Phage treatments have been explored for use in raw meat, smoked fish, cheeses, and fresh-cut fruits and vegetables.⁣ ⁣ In addition to foodborne pathogens, phages have shown potential in reducing bacteria like 𝘚𝘢𝘭𝘮𝘰𝘯𝘦𝘭𝘭𝘢 and 𝘊𝘢𝘮𝘱𝘺𝘭𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘫𝘦𝘫𝘶𝘯𝘪 in poultry, lowering contamination risks. These approaches offer alternatives to traditional antibiotic use, especially as resistance to antibiotics rises globally. ⁣ ⁣ Phages provide an innovative and natural method for controlling bacterial infections in the food supply, potentially improving both food safety and public health. 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞:- https://shorturl.at/pN6RV 𝐒𝐮𝐦𝐦𝐚𝐫𝐢𝐳𝐞𝐝 𝐛𝐲:- Alice Owiti #PhageTherapy #FoodSafety #PathogenControl #FoodIndustry #Bacteriophages #FoodPreservation #PhageTechnology #FoodProtection #SpoilagePrevention #SustainableFood

Join us in our fifth—and last—panel discussion on "𝘽𝙪𝙞𝙡𝙙𝙞𝙣𝙜 𝙖 𝘾𝙖𝙧𝙚𝙚𝙧 𝙞𝙣 𝙋𝙝𝙖𝙜𝙚 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙞𝙣 𝙇𝙤𝙬 𝙖𝙣𝙙 𝙈𝙞𝙙𝙙𝙡𝙚 𝙄𝙣𝙘𝙤𝙢𝙚 𝘾𝙤𝙪𝙣𝙩𝙧𝙞𝙚𝙨 (𝙇𝙈𝙄𝘾𝙨)" as part of our 𝗔𝗻𝘁𝗶𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗥𝗲𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲 (𝗔𝗠𝗥) and 𝗣𝗵𝗮𝗴𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 series. This event will bring together experts in phage research to explore the existing opportunities and pathways in this burgeoning field. This event will be beneficial not only to early-career scientists but also to late-career scientists. Featuring panelists include Dr. Angela Makumi from International Livestock Research Institute (ILRI) and Dr. Janet Nale from SRUC. #AntimicrobialResistance #PhageTherapy #PanelDiscussion #PhageResearch #OneHealth

Join us for an exclusive panel discussion with patients who have survived superbug infections through the power of phage therapy. Hear their personal stories, the challenges they faced, and how phages gave them a second chance at life. This event will not only be beneficial to phage researchers and scientists but also to the general public and more importantly to those patients suffering from a chronic, recurrent or antibiotic-resistant infection. Featuring panelists include Pranav Johri, Founder of Vitalis Phage Therapy, India and Christopher Shaffer, who underwent phage therapy treatment at Eliava Phage Therapy Center in Tblisi Georgia. World Health Organization (WHO) World Anti-Microbial Resistance Congress WHO Regional Office for Europe George Eliava Institute of Bacteriophages, Microbiology and Virology ReAct - Action on Antibiotic Resistance Students Against Superbugs Africa Targeting Phage Therapy Phage Asia Phage Kenya Consortium Center for Innovative Phage Applications and Therapeutics (IPATH) AMR Action Fund Henry Skinner Drugs for Neglected Diseases initiative - DNDi #AntimicrobialResistance #PhageTherapy #PanelDiscussion #PhageResearch #OneHealth #PatientStories

With the increasing rise of multi-drug resistant (MDR) pathogens, uncertainty exists in the future of global health. To date, it's unequivocal that the use of antibiotics in agro-food production is responsible for the rise of resistant pathogens and thus should be controlled effectively. For instance, globally, misuse and overuse of antibiotics within livestock farming is recognized as a driver of AMR with estimates predicting that by 2050 livestock production will fall by around 8%, economically, this will result in around 11% livestock production loss by 2050 with a higher rate in low- and middle-income countries (LMICs). Consequently, according to World Health Organization (WHO), some countries have up to 80% of their antibiotics consumption in the animal sector, primarily for growth promotion purposes. #PhageTherapy #AntimicrobialResistance #PhageResearch #FoodSector

Have you dropped your signature. 👇 Act on AMR Now. #AMR

FACTS: - 7,7 million people die from bacterial infections every year - Many of these are due to lack of access to effective antibiotics Join the global campaign From People to Leaders: Act on AMR NOW! 🫱🏽🫲🏾 🫱🏽🫲🏿 NOW is the time! Sign the Call for Global Action before United Nations #HLM #AMR #UNGA79 🌟👇🏿 Please do share in your network and in social media. We are aiming for 200 signatures from community initiatives and civil society groups! 30 to go! ⭐️⭐️ Together we can make it! 👇🏿 https://lnkd.in/dx4cchYe

𝗣𝗮𝗻𝗲𝗹𝗶𝘀𝘁 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗗𝗿. 𝗝𝗮𝗻𝗲𝘁 𝗡𝗮𝗹𝗲 — ‘𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗮 𝗖𝗮𝗿𝗲𝗲𝗿 𝗶𝗻 𝗣𝗵𝗮𝗴𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗟𝗼𝘄 𝗮𝗻𝗱 𝗠𝗶𝗱𝗱𝗹𝗲 𝗜𝗻𝗰𝗼𝗺𝗲 𝗖𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀 (𝗟𝗠𝗜𝗖𝘀)’ Dr. Janet Nale is a Microbiologist based at the SRUC (Scotland’s Rural College), Inverness campus. She is passionate about developing alternative methods to control bacterial infections, especially those that are rapidly becoming harder to treat due to multidrug resistance. She’s collaborating with researchers around the globe to understand the changes that are occurring in relevant bacteria due to antibiotic treatment and natural selection to identify better ways to control them. To do this, she is exploring naturally occurring bacterial killers, also known as bacteriophages (phages) in the environment but are largely underexplored compared to antibiotics. For nearly two decades, she has studied how the right phages for specific bacteria can be identified and to determine their potential application to replace or supplement antibiotics in various infection models. She has also analysed phage genes as useful molecular tools to track and trace infections. Her work would provide health practitioners, veterinarians, farmers and the general public with the valuable arsenals needed to understand and fight difficult-to-treat infections better and to save lives. She loves teaching and has enjoyed passing knowledge, skills and expertise to young researchers in higher education both locally and abroad. Don't miss this opportunity to gain insights and expertise from a leading expert in phage research. 📅 𝐃𝐚𝐭𝐞: September 18th, 2024 🕛 𝐓𝐢𝐦𝐞: 9:00 PM - 10:30 PM (EAT) 📍 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦: LinkedIn Live 🔗 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰: https://shorturl.at/CzP7h #AntimicrobialResistance #PhageTherapy #PanelDiscussion #AntibioticResistance #PhageResearch #OneHealth